Taiwan Liposome

$5.41
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.06 (-1.11%) Today
+$0.06 (+1.12%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell TLC and other stocks, options, and ETFs commission-free!

About TLC

Taiwan Liposome Co., Ltd. engages in the research and development of lipid-based formulation drugs. Its products are used for pain management, eye disease treatment, and cancer treatment. The company was founded by Kee Lung Hong on November 10, 1997 and is headquartered in Taipei, Taiwan. The listed name for TLC is Taiwan Liposome Company, Ltd. American Depository Shares.

CEO
Keelung Hong
Employees
—
Headquarters
Taipei, Taipei City
Founded
1997
Market Cap
252.75M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
16.89K
High Today
$5.50
Low Today
$5.34
Open Price
$5.45
Volume
14.98K
52 Week High
$12.65
52 Week Low
$2.48

TLC Earnings

-$0.29
-$0.19
-$0.10
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 12, Pre-Market

You May Also Like

AERI
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure